Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Andy Ni"'
Autor:
Jasmine S. Sukumar, Sagar Sardesai, Andy Ni, Nicole Williams, Kai Johnson, Dionisia Quiroga, Bhuvana Ramaswamy, Robert Wesolowski, Mathew Cherian, Daniel G. Stover, Margaret Gatti‐Mays, Ashley Pariser, Preeti Sudheendra, Mridula A. George, Maryam Lustberg
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background The optimal adjuvant endocrine therapy (ET) in hormone receptor positive (HR+) and human epidermal growth factor receptor 2 positive (HER2+) premenopausal breast cancer (BC) remains unclear. Moreover, the benefit and clinical indi
Externí odkaz:
https://doaj.org/article/95ee2addb7d44134809b3c59d72db720
Autor:
Anne L. Loeser, Lucy Gao, Aditya Bardia, Mark E. Burkard, Kevin M. Kalinsky, Jeffrey Peppercorn, Hope S. Rugo, Martha Carlson, Janice Cowden, Lesley Glenn, Julia Maues, Sheila McGlown, Andy Ni, Natalia Padron, Maryam Lustberg
Publikováno v:
Breast Cancer Research and Treatment. 196:549-563
Although metastatic breast cancer (MBC) is treatable, it is not curable and most patients remain on treatment indefinitely. While oncologists commonly prescribe the recommended starting dose (RSD) from the FDA-approved label, patient tolerance may di
Autor:
Gregory J. Riely, Marc Ladanyi, David B. Solit, Michael F. Berger, David M. Hyman, Charles M. Rudin, Nikolaus Schultz, Barry S. Taylor, José Baselga, Jamie E. Chaft, Mark G. Kris, Valerie W. Rusch, Ryma Benayed, Dalicia N. Reales, Matthew D. Hellmann, Alexander Drilon, Paul K. Paik, Helena A. Yu, Bob T. Li, Michelle S. Ginsberg, Natasha Rekhtman, Ahmet Zehir, Aphrothiti J. Hanrahan, Hannah C. Johnsen, Sizhi Paul Gao, Gowtham Jayakumaran, Philip Jonsson, Ritika Kundra, Andy Ni, Matthew T. Chang, JianJiong Gao, Debyani Chakravarty, David Barron, Maria E. Arcila, Hyunjae R. Kim, Emmet J. Jordan
Breakdown of RET and ROS1 fusion positive patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4ac8797a6788a311a0d4f488e23235
https://doi.org/10.1158/2159-8290.22531744
https://doi.org/10.1158/2159-8290.22531744
Autor:
Matthew D. Hellmann, Jamie E. Chaft, Charles M. Rudin, Mark G. Kris, Niamh M. Long, Darragh F. Halpenny, Elizabeth Panora, Olivia Wilkins, Maya Gambarin-Gelwan, Mario E. Lacouture, Andy Ni, Andrew J. Plodkowski, Hira Rizvi, Fernando C. Santini
Retreatment Cohort - Initial irAEs: Clinical Characteristics and Features
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28624098d1631020b599811008fc7822
https://doi.org/10.1158/2326-6066.22539397.v1
https://doi.org/10.1158/2326-6066.22539397.v1
Autor:
Gregory J. Riely, Marc Ladanyi, David B. Solit, Michael F. Berger, David M. Hyman, Charles M. Rudin, Nikolaus Schultz, Barry S. Taylor, José Baselga, Jamie E. Chaft, Mark G. Kris, Valerie W. Rusch, Ryma Benayed, Dalicia N. Reales, Matthew D. Hellmann, Alexander Drilon, Paul K. Paik, Helena A. Yu, Bob T. Li, Michelle S. Ginsberg, Natasha Rekhtman, Ahmet Zehir, Aphrothiti J. Hanrahan, Hannah C. Johnsen, Sizhi Paul Gao, Gowtham Jayakumaran, Philip Jonsson, Ritika Kundra, Andy Ni, Matthew T. Chang, JianJiong Gao, Debyani Chakravarty, David Barron, Maria E. Arcila, Hyunjae R. Kim, Emmet J. Jordan
Co-occurring Level 1-3 alterations by MSK-IMPACT in 52 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55d43a1fb3fc0fe410c4b06d518f11ca
https://doi.org/10.1158/2159-8290.22531753.v1
https://doi.org/10.1158/2159-8290.22531753.v1
Autor:
Gregory J. Riely, Marc Ladanyi, David B. Solit, Michael F. Berger, David M. Hyman, Charles M. Rudin, Nikolaus Schultz, Barry S. Taylor, José Baselga, Jamie E. Chaft, Mark G. Kris, Valerie W. Rusch, Ryma Benayed, Dalicia N. Reales, Matthew D. Hellmann, Alexander Drilon, Paul K. Paik, Helena A. Yu, Bob T. Li, Michelle S. Ginsberg, Natasha Rekhtman, Ahmet Zehir, Aphrothiti J. Hanrahan, Hannah C. Johnsen, Sizhi Paul Gao, Gowtham Jayakumaran, Philip Jonsson, Ritika Kundra, Andy Ni, Matthew T. Chang, JianJiong Gao, Debyani Chakravarty, David Barron, Maria E. Arcila, Hyunjae R. Kim, Emmet J. Jordan
Types of Clinical trials patients enrolled to according to level 1-4 and UMD assigned samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d5aaa5ae44ad3ed0b6c03c6bf38eb1
https://doi.org/10.1158/2159-8290.22531735.v1
https://doi.org/10.1158/2159-8290.22531735.v1
Autor:
Gregory J. Riely, Marc Ladanyi, David B. Solit, Michael F. Berger, David M. Hyman, Charles M. Rudin, Nikolaus Schultz, Barry S. Taylor, José Baselga, Jamie E. Chaft, Mark G. Kris, Valerie W. Rusch, Ryma Benayed, Dalicia N. Reales, Matthew D. Hellmann, Alexander Drilon, Paul K. Paik, Helena A. Yu, Bob T. Li, Michelle S. Ginsberg, Natasha Rekhtman, Ahmet Zehir, Aphrothiti J. Hanrahan, Hannah C. Johnsen, Sizhi Paul Gao, Gowtham Jayakumaran, Philip Jonsson, Ritika Kundra, Andy Ni, Matthew T. Chang, JianJiong Gao, Debyani Chakravarty, David Barron, Maria E. Arcila, Hyunjae R. Kim, Emmet J. Jordan
Supplementary Table S1: List of actionable genes and potential matched therapy Supplementary Table S2: List of co-occurring Level 1-4 mutations Supplementary Table S3: EGFR mutations identified and associated therapy Supplementary Table S4: List of 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5073f11f7baeb4b6075190c0b7b5c8
https://doi.org/10.1158/2159-8290.22531729.v1
https://doi.org/10.1158/2159-8290.22531729.v1
Autor:
Matthew D. Hellmann, Jamie E. Chaft, Charles M. Rudin, Mark G. Kris, Niamh M. Long, Darragh F. Halpenny, Elizabeth Panora, Olivia Wilkins, Maya Gambarin-Gelwan, Mario E. Lacouture, Andy Ni, Andrew J. Plodkowski, Hira Rizvi, Fernando C. Santini
Patients with Advanced NSCLC Treated at MSKCC with Immunotherapy From April 2011 to May 2016
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35380d5807ed36c509bd0cbd61a52554
https://doi.org/10.1158/2326-6066.22539400
https://doi.org/10.1158/2326-6066.22539400
Autor:
Gregory J. Riely, Marc Ladanyi, David B. Solit, Michael F. Berger, David M. Hyman, Charles M. Rudin, Nikolaus Schultz, Barry S. Taylor, José Baselga, Jamie E. Chaft, Mark G. Kris, Valerie W. Rusch, Ryma Benayed, Dalicia N. Reales, Matthew D. Hellmann, Alexander Drilon, Paul K. Paik, Helena A. Yu, Bob T. Li, Michelle S. Ginsberg, Natasha Rekhtman, Ahmet Zehir, Aphrothiti J. Hanrahan, Hannah C. Johnsen, Sizhi Paul Gao, Gowtham Jayakumaran, Philip Jonsson, Ritika Kundra, Andy Ni, Matthew T. Chang, JianJiong Gao, Debyani Chakravarty, David Barron, Maria E. Arcila, Hyunjae R. Kim, Emmet J. Jordan
Breakdown of MAP2K1, RAF1, ARAF, FGFR3-TACC3 fusion and CDKN2A loss patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bde891cb25223ddac7c691d1590525d
https://doi.org/10.1158/2159-8290.22531741
https://doi.org/10.1158/2159-8290.22531741
Autor:
Matthew D. Hellmann, Jamie E. Chaft, Charles M. Rudin, Mark G. Kris, Niamh M. Long, Darragh F. Halpenny, Elizabeth Panora, Olivia Wilkins, Maya Gambarin-Gelwan, Mario E. Lacouture, Andy Ni, Andrew J. Plodkowski, Hira Rizvi, Fernando C. Santini
Retreatment Cohort - Recurrent irAEs: Characteristics of The Recurrent Immune-Related Toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf3d637d0fc4a7f43fa7d49b6434ee2
https://doi.org/10.1158/2326-6066.22539394.v1
https://doi.org/10.1158/2326-6066.22539394.v1